ekonominyheter

TranslateRSSMobil
Exelixis' Cometriq Makes a Comeback

Exelixis' Cometriq Makes a Comeback

Fool.com 4/11 22:40

Exelixis reports third quarter earnings, but it's the data testing Cometriq in lung cancer that's caused the stock pop.

Till artikeln

Ekonomi Nyheter .se - Innehåll

 

 

 

 

DMCA.com Protection Status